case_images: PMC11346312_01
case_images: Line graph showing average glucose and ketone levels in mmol/L over 21 weeks.
case_images: fnut-11-1394679-g001.jpg
case_images: PMC11346312_01_fnut-11-1394679-g001.jpg
case_images: fig1
case_images: Blood glucose and BHB level tracking was initiated and showed nutritional ketosis was achieved at 1.0 mmol/L (Figure 1).
case_images: Line graph depicting the reduction in GAD-7 total scores across four assessment points over a 21-week period.
case_images: fnut-11-1394679-g002.jpg
case_images: PMC11346312_01_fnut-11-1394679-g002.jpg
case_images: fig2
case_images: Scores at the onset indicated mild symptoms, which decreased over the course of the intervention, ending in a normal range (Figure 2).
case_images: Line graph depicting the reduction in DASS total and subscale scores across four assessment points over a 21-week period.
case_images: fnut-11-1394679-g003.jpg
case_images: PMC11346312_01_fnut-11-1394679-g003.jpg
case_images: fig3
case_images: The 42-item version of the DASS was administered with scores indicating a reduction in symptoms (Figure 3).
case_images: Line graph depicting the reduction in PCL-5 total and criterio subscales across four assessment points over a 21-week period.
case_images: fnut-11-1394679-g004.jpg
case_images: PMC11346312_01_fnut-11-1394679-g004.jpg
case_images: fig4
case_images: Subsequent assessments showed a consistent decrease in these scores, with marked improvements observed in both Criterion D and Criterion E (Figure 4).